Global Ganja Report

The Oakland City Council on July 26 passed an ordinance that will double the number of medical marijuana dispensaries in the city, to eight from the current four—the Oakland Patient Center, the Purple Heart Patient Center, Coffeeshop Blue Sky, and the Harborside Health Center. The new ordinance was passed with an amendment that provides the city with access to all the dispensaries' financial information. And accompanying legislation imposes a $5,000 application fee and a $60,000 annual regulatory fee on each dispensary. The Council put off discussion of amending the city's cultivation ordinance, which would regulate large-scale cannabis farms, until the Public Safety Committee reconvenes in the fall. (Office of the City Clerk, City of Oakland, July 26; San Francisco Chronicle's Oakland Blog, July 13)

The country's leading medical marijuana advocacy group, Americans for Safe Access (ASA), with the Coalition for Rescheduling Cannabis (CRC), on July 21 appealed a recent decision by the federal government to keep marijuana classified as a dangerous drug with no medical value. The appeal to the DC Circuit comes just two weeks after the DEA denied a 2002 petition to reschedule marijuana filed by a coalition of patients and advocacy groups. ASA will argue in a forthcoming appeal brief that the federal government erred by keeping cannabis out of reach for millions of patients throughout the US.

Entertainment Weekly's Inside TV blog reports July 20 that the Discovery Channel has announced a "docu-soap reality show" entitled Weed Wars, set in Oakland's Harborside Health Center, the USA's largest medicinal cannabis distributorship. Set to air this fall, Weed Wars will follow the day-to-day dealings of Steve DeAngelo, owner of the establishment, which serves some 80,000 clients. 

New Jersey Gov. Chris Christie held a press conference July 19 to announce his plans to "begin work immediately" on his state's pending medical marijuana program. "We're moving forward with the program as it was set up," said Christie, with the expectation that licensed Alternative Treatment Centers could be up and operating as early as the end of 2011. Christie said he believed "the need to provide compassionate pain relief to these citizens of our state outweighs the risk we are taking in moving forward with the program." Christie's announcement comes in spite of threats from US Attorneys on the issue and a June 29 memorandum from Deputy Attorney General James Cole.

The East Bay Express' Legalization Nation blog reports July 13 that organizers expect up to 30,000 to pack Frank H. Ogawa Plaza in front of Oakland City Hall on Sept 3-4 for the International Cannabis and Hemp Expo 2011—dubbed "Mardi Grass" by blogger David Downs. Tickets for the event just went on sale for $18, marking the first time Oakland has turned over public space for a a paid cannabis-oriented event. Plans call for three entertainment stages, some 400 industry vendors, dozens of food trucks, guest celebrities, and heavy hitters from the movement. The expo will also feature an open-air "215" area for medical cannabis patients.

We have noted before that the cannabis industry has a huge carbon footprint—something of a dirty little secret for the legalization movement. David Downs in the July 13 issue of East Bay Express has a fascinating cover-story, "How Green Is Your Pot?" Traveling to backwoods Humboldt County, Downs finds: "A new collective is trying to sell sustainable, organically grown marijuana, but patients are hooked on indoor weed that wastes energy and pollutes the planet."

Less than two months after patient advocates filed a lawsuit compelling the federal government to answer a nine-year-old petition to reschedule medical marijuana, the Drug Enforcement Administration (DEA) on July 8 made official its denial of the petition in the Federal Register. The Coalition for Rescheduling Cannabis (CRC), which includes patient advocacy group Americans for Safe Access (ASA), filed the petition in 2002 seeking to reclassify cannabis from its current status as a dangerous drug with no medical value, but never heard from the federal government until it received the denial.

Starting July 6, the International Cannabinoid Research Society (ICRS) will hold its 21st annual symposium in St. Charles, Ill., just outside of Chicago. Notably, this year's symposium is sponsored by an array of pharmaceutical companies, the US National Institute on Drug Abuse (NIDA), and ElSohly Laboratories of Oxford, Miss., the federal government's only licensed source of research-grade cannabis.